MAXIMIZING ONCOLOGY INVESTIGATION WITH BUILT-IN KRAS ASSAY COMPANIES AND RAS ASSAYS

from the promptly evolving discipline of oncology research, correct and efficient mutation screening is important for developing qualified therapies. The KRAS solutions Platform plays a pivotal position With this landscape by featuring complete alternatives for KRAS mutation profiling and analysis. KRAS mutations, present in close to ninety five% o